Mitsubishi Corporation

The pharmaceutical industry is no stranger to fierce competition, but the battle between Vertex Pharmaceuticals Incorporated ’s Incivek (telaprevir) and Merck & Co., Inc. ’s Victrelis (boceprevir) s

Japan’s next regular revision of drug reimbursement prices will see an average cut of around 4.4% across the pharma industry, although the impact by individual company varies widely according to disco

Asahi Kasei Corp. is to launch in December a DKK6 ($0.88) per share voluntary tender offer for Veloxis Pharmaceuticals AS (formerly LifeCycle Pharma), a one-product company focused on post-transpla

The US Supreme Court has refused to review standards for determining obviousness via inter partes patent reviews, as well as procedures for affirming such determinations on appeal. Originators Senj